Evidence map›Paper›PMID 30783117›Full record

ArticleScientific reports2019

Fasciola hepatica GST downregulates NF-κB pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model.

Vasti Aguayo, Bianca N Valdés Fernandez, Madeline Rodríguez-Valentín, Caleb Ruiz-Jiménez, Marcos J Ramos-Benítez, Loyda B Méndez, Ana M Espino

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Design and Expression ofInternational journal of molecular sciences · 2025
    Article
  8. Pathogens (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Microbiology spectrum · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Vasti AguayoUniversity of Puerto Rico, Medical Sciences Campus, Department of Microbiology, San Juan, Puerto Rico.
Bianca N Valdés FernandezUniversity of Puerto Rico, Rio Piedras Campus, Department of Biology, San Juan, Puerto Rico.
Madeline Rodríguez-ValentínDepartment of Microbiology, Universidad Central del Caribe, Bayamon, Puerto Rico.
Caleb Ruiz-JiménezUniversity of Puerto Rico, Medical Sciences Campus, Department of Microbiology, San Juan, Puerto Rico.
Marcos J Ramos-BenítezUniversity of Puerto Rico, Medical Sciences Campus, Department of Microbiology, San Juan, Puerto Rico.
Loyda B MéndezSchool of Science & Technology Universidad del Este, Carolina, Puerto Rico.
Ana M EspinoUniversity of Puerto Rico, Medical Sciences Campus, Department of Microbiology, San Juan, Puerto Rico. ana.espino1@upr.edu.
University of Puerto Rico, Medical Sciences Campus · PRCentral University of the Caribbean · PRUniversidad Del Este · PRUniversity of Puerto Rico at Río Piedras · PR

Funding

Translational Science InitiativeP40OD012217 · OD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CARLOS A SARIOL · 2012 to 2026
$40.4M
Upgrade Laboratories Facilities at UPR-Rio PiedrasR25GM061151 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI CARBALLEIRA, NESTOR MANUEL · 2001 to 2023
$32.5M
RISE Option III: MBRS RISE at the UPR Medical Sciences CampusR25GM061838 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CADILLA, CARMEN LYDIA · 2000 to 2021
$25.5M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
NIGMS NIH HHS R25 GM061151NIGMS NIH HHS R25 GM061838NIH HHS P40 OD012217NIMHD NIH HHS G12 MD007600
6 · The paper itself

Abstract

Parasitic helminths and helminth-derived molecules have demonstrated to possess powerful anti-inflammatory properties and confirmed therapeutic effects on inflammatory diseases. The helminth Fasciola hepatica has been reported to suppress specific Th1 specific immune responses induced by concurrent bacterial infections, thus demonstrating its anti-inflammatory ability in vivo. In this study, we demonstrate that native F. hepatica glutathione S-transferase (nFhGST), a major parasite excretory-secretory antigen, majorly comprised of Mu-class GST isoforms, significantly suppresses the LPS-induced TNFα and IL1β of mouse bone-marrow derived macrophages in vitro and the pro-inflammatory cytokine/chemokine storm within C57BL/6 mice exposed to lethal doses of LPS increasing their survival rate by more than 85%. Using THP1-Blue CD14 cells, a human monocyte cell line, we also demonstrate that nFhGST suppresses NF-κB activation in response to multiple TLR-ligands, including whole bacteria clinical isolates and this suppression was found to be dose-dependent and independent of the timing of exposure. Moreover, the suppressive effect of nFhGST on NF-κB activation was shown to be independent of enzyme activity or secondary structure of protein. As part of its anti-inflammatory effect nFhGST target multiple proteins of the canonic and non-canonic NF-κB signaling pathway as well as also JAK/STAT pathway. Overall, our results demonstrate the potent anti-inflammatory properties of nFhGST and its therapeutic potential as an anti-inflammatory agent.

Indexed as

AnimalsCytokinesDisease Models, AnimalFasciola hepaticaFemaleGlutathione TransferaseHelminth ProteinsHumansMiceMice, Inbred BALB CNF-kappa BShock, SepticSignal TransductionTHP-1 CellsCytokinesGlutathione TransferaseHelminth ProteinsNF-kappa B

Identifiers

PMID30783117
PMCPMC6381083
OpenAlexW2916122784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.